Profile
Karen B.
Chapman is the founder of Origen Therapeutics, Inc. She worked as the Vice President-Research at OncoCyte Corp.
from 2011 to 2017.
Chapman holds a graduate degree from Cornell University and a doctorate degree from The Johns Hopkins University School of Medicine, which she received in 1991.
Former positions of Karen B. Chapman
| Companies | Position | End |
|---|---|---|
| ONCOCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 22/03/2017 |
Origen Therapeutics, Inc.
 Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Founder | - |
Training of Karen B. Chapman
| Cornell University | Graduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Origen Therapeutics, Inc.
Origen Therapeutics, Inc. BiotechnologyHealth Technology Origen Therapeutics, Inc. is a biotechnology firm. It develops products from ots avian transgenic platform. The company was founded on April 22, 1997 and is headquartered in Emeryville, CA. | Health Technology |
- Stock Market
- Insiders
- Karen B. Chapman
